EG i21
Alternative Names: EG-i21Latest Information Update: 04 Feb 2021
At a glance
- Originator enGene
- Class Antineoplastics; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 01 Jan 2021 Early research in Solid tumours in Canada (Parenteral) (enGene pipeline, January 2021)